Managed Markets
Network

Make the move to a generic drug for relapsing-MS

Oncology

News

MORE >>>

Review Finds Mixed Results for APMs and New Care Delivery Models in Cancer

Review Finds Mixed Results for APMs and New Care Delivery Models in Cancer

September 23, 2018

Bidens Celebrate Progress, Highlight Need for More at Biden Cancer Summit

September 21, 2018 – Jaime Rosenberg

More Data Necessary to Determine Best Treatment Option in Basal Cell Carcinoma

September 21, 2018 – Samantha DiGrande

This Week in Managed Care: September 21, 2018

September 21, 2018 –

Journals

MORE >>>

From the Editor-in-Chief: What Happens Next?

August 22, 2018 – Joseph Alvarnas, MD

Survivorship Care Throughout the Cancer Journey

August 22, 2018 – Don Champlain, MHA, RN, and Lucio Gordan, MD

Conference Coverage: NCCN Policy Summit 2018

August 22, 2018 – Coverage by Mary Caffrey

Information from Industry

Introducing a new FDA-approved therapy for relapsed/refractory AML

Conferences

MORE >>>

Dr Sara M. Tolaney on Challenges With Treating, Role of Clinical Trials in HER2-Positive Breast Cancer

August 08, 2018

Dr Michael Thompson Outlines Challenges With the Mass Adoption of EHRs, Precision Medicine

July 25, 2018

Dr Sara M. Tolaney Discusses the Role of Adjuvant Therapy in HER2-Positive Breast Cancer

July 23, 2018

Multimedia

MORE >>>

Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News

Dr Denalee O'Malley Highlights Gaps in Cancer Treatment Communication

ACCOUNTABLE CARE DELIVERY CONGRESS

CONTINUING EDUCATION

Interactive Tools

Managed Care Podcast

Panel Discussions

Information for Reviewers

Information for Authors

Formulary Central

Clinical Study Summaries

Study Summaries

AJMC Resources

Terms & Conditions

Like Us On Facebook

Follow Us On Twitter

Check us out on LinkedIn

Follow us on Instagram

Subscribe us on YouTube

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.

×

Not a member? Sign up now!